Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Hyperbaric Oxygen Therapy (HBOT) for the Treatment of COVID-19 Patients With Mild-to-moderate Respiratory Distress

NCT04800120 is registered in ClinicalTrials.gov with Steward St. Elizabeth's Medical Center of Boston, Inc. as lead sponsor.

NCT NCT04800120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04800120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Hyperbaric Oxygen Therapy (HBOT) for the Treatment of COVID-19 Patients With Mild-to-moderate Respiratory Distress
Lead sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 15, 2021
Completion date
March 1, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19